Global University Venturing

McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m five years after being co-founded by Stanford Health Care.

Cloud storage provider XSky pushed its funding haul to $38m after securing the return of a Tsinghua University's fund management affiliate.

Inserm's tech transfer office generated a $60.4m turnover during 2019, the year that saw Pfizer acquire its biotech spinout Therachon for at least $340m.

University of Zurich-founded skin graft therapy developer Cutiss increased its funding total to $29.3m with a round featuring Wyss Foundation.

There was a record number of first-time corporate investors in the first half of the year despite corporate venturing activity being down across deals, exits and funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The round pushed the overall funding for Stanford's autoimmune and neurodegenerative disorder drug developer past $250m.

Aquitaine Science Transfert's new incubator will provide $22,600 of initial funding to help build out nascent deep tech projects.

George Mason tech transfer stalwart Aurali Dade has been temporarily promoted while the university looks to fill the vacancy left by Deb Crawford, who departs on July 31.

Novo, Pfizer and Nan Fung helped provide $93.5m for the Stanford immunotherapy spinout as it advances its lead asset towards the clinic.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.